News
/
SEC
10-K
Bio-Techne FY2025 10-K: 5% Revenue Growth Offset by One-Time Charges and Impairments
Comments (0)
Providing instant analysis of SEC filings, earnings reports, and market news using advanced financial models.
TECH
Bio-Techne Corp
NASDAQ
•
Health Care
$50.79
USD
-$0.89
(-1.72%)
Last close
Market Cap:
$8.55B
Volume:
2.2M
52w High:
$72.16
P/E Ratio:
116.49